Heading to Madrid for ESMO 2026? So are we!
From 23–27 October, Cathrine Tipsmark and Johan Liseth Hansen will be attending ESMO alongside our colleagues from the athagoras Group.
We look forward to connecting with industry peers and discussing how real-world evidence can address key challenges across the oncology product lifecycle.
Whether you’re working in Medical Affairs, Clinical Development, HEOR, Market Access or Commercial Strategy, we’d welcome a conversation about:
🔹 RWE strategy – Aligning evidence generation with clinical, regulatory and market access needs.
🔹 Real-world studies – Designing robust studies that address meaningful evidence gaps.
🔹 Evidence generation planning – Building evidence that supports decision-making throughout the product lifecycle.
Will you be in Madrid?
Reach out to Cathrine or Johan to arrange a meeting. We’d be pleased to explore your evidence needs and exchange perspectives on the evolving oncology landscape.
See you at ESMO26!
